New Millennium Group LLC Gilead Sciences, Inc. Transaction History

New Millennium Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$73.27 - $83.09 $73 - $83	1 Added 3.23%	32 $2,000
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $684 - $780	-9 Reduced 22.5%	31 $2,000
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $5,334 - $6,077	-69 Reduced 63.3%	40 $3,000
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $1,558 - $2,236	-25 Reduced 18.66%	109 $9,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $59 - $68	1 Added 0.75%	134 $8,000
Q2 2022 Aug 18, 2022	BUY	$57.72 - $65.01 $7,676 - $8,646	133 New	133 $8,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

Stay updated on New Millennium Group LLC with notifications on news.